Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Komp

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Cancer Chemotherapy Reports|March 1, 1975
5-[3,3-Bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in the treatment of childhood malignancyD M Komp, V J Land, R Nitschke, et al.
Cancer Treatment Reports|August 1, 1977
Evaluation of a MOPP-type regimen in histiocytosis X--a Southwest Oncology Group studyD M Komp, M Silva-Sosa, T Miale, et al.
Cancer Chemotherapy Reports|September 1, 1974
Response of childhood histiocytosis X to procarbazine (NSC-77213)D M Komp, H A Britton, T J Vietti, et al.
Cancer|February 15, 1981
A staging system for histiocytosis X: a Southwest Oncology Group StudyD M Komp, J Herson, K A Starling, et al.
Virginia Medical Monthly|December 1, 1972
The management of abdominal malignancy in childrenD M Komp, R D Marks, A Shaw, et al.
Journal of Clinical Pharmacology|February 1, 1978
Toxicity study of cytosine arabinoside and methotrexate in the maintenance therapy of childhood leukemia. A Southwest Oncology Group studyR Nitschke, D M Komp, S K Morgan, et al.
The New England Journal of Medicine|March 15, 1973
Simultaneous occurrence of "American Burkitt's lymphoma" in neighborsP H Levine, S G Sandler, D M Komp, et al.
Pediatric Research|February 1, 1974
The effect of cancer chemotherapeutic agents on fibrin formation and stabilization in vitroD M Komp, R L Lyles, T H Boyd, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1981
Spontaneously acquired Factor IX inhibitors in childhoodB W Berman, S McIntosh, L P Clyne, et al.
Cancer Treatment Reports|August 1, 1979
ICRF-159 (razoxane) in the treatment of pediatric solid tumors: a Southwest Oncology Group studyP G Dyment, K A Starling, V J Land, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy Reports|March 1, 1975
5-[3,3-Bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in the treatment of childhood malignancyD M Komp, V J Land, R Nitschke, et al.
Cancer Treatment Reports|August 1, 1977
Evaluation of a MOPP-type regimen in histiocytosis X--a Southwest Oncology Group studyD M Komp, M Silva-Sosa, T Miale, et al.
Cancer Chemotherapy Reports|September 1, 1974
Response of childhood histiocytosis X to procarbazine (NSC-77213)D M Komp, H A Britton, T J Vietti, et al.
Cancer|February 15, 1981
A staging system for histiocytosis X: a Southwest Oncology Group StudyD M Komp, J Herson, K A Starling, et al.
Virginia Medical Monthly|December 1, 1972
The management of abdominal malignancy in childrenD M Komp, R D Marks, A Shaw, et al.
Journal of Clinical Pharmacology|February 1, 1978
Toxicity study of cytosine arabinoside and methotrexate in the maintenance therapy of childhood leukemia. A Southwest Oncology Group studyR Nitschke, D M Komp, S K Morgan, et al.
The New England Journal of Medicine|March 15, 1973
Simultaneous occurrence of "American Burkitt's lymphoma" in neighborsP H Levine, S G Sandler, D M Komp, et al.
Pediatric Research|February 1, 1974
The effect of cancer chemotherapeutic agents on fibrin formation and stabilization in vitroD M Komp, R L Lyles, T H Boyd, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1981
Spontaneously acquired Factor IX inhibitors in childhoodB W Berman, S McIntosh, L P Clyne, et al.
Cancer Treatment Reports|August 1, 1979
ICRF-159 (razoxane) in the treatment of pediatric solid tumors: a Southwest Oncology Group studyP G Dyment, K A Starling, V J Land, et al.
Pageof 8